Leadman(SZ:300289) Jin Rong Jie·2025-08-27 14:11Group 1 - The stock price of Lidman is reported at 8.54 yuan, down 0.35 yuan from the previous trading day, with a decline of 3.94% [1] - The highest intraday price reached 8.92 yuan, while the lowest dipped to 8.53 yuan, with a trading volume of 364,600 shares and a transaction amount of 318 million yuan [1] - Lidman operates in the medical device industry, focusing on in vitro diagnostic reagents, diagnostic instruments, and biochemical raw materials, primarily used in clinical testing and food safety detection [1] Group 2 - For the first half of 2025, the company reported total operating revenue of 160 million yuan, a year-on-year decrease of 14.80%, and a net loss attributable to shareholders of 4.2452 million yuan [1] - The decline in performance is mainly attributed to industry procurement policies, the splitting of testing packages, and intensified market competition, with core business revenue from in vitro diagnostic reagents dropping by 28.13% [1] - However, revenue from diagnostic instruments and accessories increased to 22.7416 million yuan, reflecting a year-on-year growth of 106.73% [1] Group 3 - On August 27, the net outflow of main funds was 46.4047 million yuan, accounting for 1% of the circulating market value [1] - Over the past five days, the net outflow of main funds totaled 189.5546 million yuan, representing 4.09% of the circulating market value [1]